This inventor holds 2 USPTO granted patents. Top assignees: Takeda Chemical Industries, Inc., Takeda Pharmaceutical Company Limited. Active years: 2003-2008.
Company Filing History:
1 out of 1,858 
1 out of 1,226 
Years Active: 2003-2008
Title: Taeko Hattori: Innovator in CCR5 Antagonist Research
Introduction
Taeko Hattori is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target CCR5 receptors. Her work is crucial in the fight against HIV and related infectious diseases.
Latest Patents
Taeko Hattori holds 2 patents related to cyclic amine compounds as CCR5 antagonists. These compounds have shown potent CCR5 antagonistic activity and can be advantageously used for the treatment or prevention of various HIV infections in humans, including AIDS. The detailed chemical formulations of these compounds highlight their potential therapeutic applications.
Career Highlights
Throughout her career, Taeko Hattori has worked with notable companies such as Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited. Her experience in these organizations has allowed her to contribute to significant advancements in pharmaceutical research and development.
Collaborations
Taeko has collaborated with esteemed colleagues, including Shinichi Imamura and Shohei Hashiguchi. These partnerships have fostered innovation and have been instrumental in her research endeavors.
Conclusion
Taeko Hattori's work in developing CCR5 antagonists represents a vital advancement in the treatment of HIV. Her contributions to medicinal chemistry continue to impact the field positively.